Avonex

GPTKB entity

Statements (61)
Predicate Object
gptkbp:instance_of gptkb:pharmaceuticals
gptkbp:administered_by intramuscular injection
gptkbp:approves gptkb:1996
gptkbp:chemical_formula C634 H1009 N169 O198 S4
gptkbp:clinical_trial Phase III
gptkbp:contraindication severe liver disease
hypersensitivity to interferon beta
gptkbp:dosage_form gptkb:Software_Solutions
gptkbp:drug_interactions anticoagulants
antidepressants
other immunosuppressants
gptkbp:effective_date 1996-04-01
gptkbp:financial_support Avonex Support Program
gptkbp:formulation lyophilized powder
gptkbp:frequency once a week
https://www.w3.org/2000/01/rdf-schema#label Avonex
gptkbp:indication gptkb:relapsing_forms_of_multiple_sclerosis
gptkbp:ingredients interferon beta-1a
gptkbp:is_monitored_by liver function tests
complete blood count
gptkbp:manufacturer gptkb:Biogen
gptkbp:marketed_as gptkb:Canada
gptkb:European_Union
gptkb:United_States
gptkbp:mechanism_of_action immunomodulatory
gptkbp:patient_education storage instructions
side effects management
injection technique
when to seek medical attention
gptkbp:patient_population adults
children over 12 years
gptkbp:pharmacokinetics excreted in urine
metabolized in the liver
subcutaneous absorption
half-life of 8 hours
gptkbp:previous_name interferon beta-1a
gptkbp:price approximately $60,000 per year
varies by insurance
gptkbp:provides_guidance_on MS treatment guidelines
neurology practice guidelines
gptkbp:recommissioned with sterile water for injection
gptkbp:route_of_administration intramuscular
gptkbp:side_effect gptkb:anemia
gptkb:depression
fatigue
headache
muscle pain
injection site reactions
thrombocytopenia
flu-like symptoms
elevated liver enzymes
gptkbp:storage refrigerated
gptkbp:trade gptkb:Avonex
gptkbp:used_for gptkb:multiple_sclerosis
gptkbp:weight 150 k Da
gptkbp:bfsParent gptkb:Biogen_MA_Inc.
gptkb:Biogen_Idec
gptkb:Biogen_Inc.
gptkb:Rebif
gptkb:BIIB
gptkbp:bfsLayer 5